Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Equity (2016 - 2025)

Historic Return on Equity for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to 0.45%.

  • Abvc Biopharma's Return on Equity rose 25600.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year increase of 25600.0%. This contributed to the annual value of 4.24% for FY2024, which is 5500.0% down from last year.
  • Abvc Biopharma's Return on Equity amounted to 0.45% in Q3 2025, which was up 25600.0% from 0.52% recorded in Q2 2025.
  • Abvc Biopharma's 5-year Return on Equity high stood at 0.45% for Q3 2025, and its period low was 18.43% during Q2 2023.
  • Its 5-year average for Return on Equity is 3.74%, with a median of 2.77% in 2023.
  • In the last 5 years, Abvc Biopharma's Return on Equity plummeted by -164300bps in 2023 and then surged by 138200bps in 2024.
  • Over the past 5 years, Abvc Biopharma's Return on Equity (Quarter) stood at 1.38% in 2021, then crashed by -165bps to 3.65% in 2022, then skyrocketed by 56bps to 1.6% in 2023, then plummeted by -129bps to 3.67% in 2024, then soared by 88bps to 0.45% in 2025.
  • Its Return on Equity stands at 0.45% for Q3 2025, versus 0.52% for Q2 2025 and 0.71% for Q1 2025.